Market revenue in 2023 | USD 123.1 million |
Market revenue in 2030 | USD 185.6 million |
Growth rate | 6% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 26% in 2023. Horizon Databook has segmented the Spain regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Spain is one of the most important markets within Europe for medical products. Small- & medium-sized companies dominate 90% of the market and are responsible for more than 40% of sales, whereas largesized companies, account for 8% to 10% of sales, generating approximately 60% of sales for the country.
Demand for Regulatory affairs is expected to rise in the coming years, as imports of medical devices from countries such as the U.S. and Germany are increasing. Increase in the number of manufacturing and research facilities in the country is anticipated to fuel the demand for regulatory services, such as legal representation & audit.
For instance, in 2021, AGC, Inc. announced the expansion of its production capabilities and establishment of a new R&D facility of its pharmaceutical CDMO subsidiary located in Spain.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain regulatory affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Spain regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account